Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001576885-25-000065
Filing Date
2025-05-13
Accepted
2025-05-13 16:36:39
Documents
70
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q abos-20250331.htm   iXBRL 10-Q 839776
2 EX-10.1 abos-20250331x10qxexx101.htm EX-10.1 107944
3 EX-31.1 abos-20250331x10qxexx311.htm EX-31.1 10681
4 EX-31.2 abos-20250331x10qxexx312.htm EX-31.2 10644
5 EX-32.1 abos-20250331x10qxexx321.htm EX-32.1 5019
6 EX-32.2 abos-20250331x10qxexx322.htm EX-32.2 5062
12 image_0a.jpg GRAPHIC 147
  Complete submission text file 0001576885-25-000065.txt   6271074

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abos-20250331.xsd EX-101.SCH 44169
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abos-20250331_cal.xml EX-101.CAL 95354
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abos-20250331_def.xml EX-101.DEF 213039
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abos-20250331_lab.xml EX-101.LAB 635358
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abos-20250331_pre.xml EX-101.PRE 429943
73 EXTRACTED XBRL INSTANCE DOCUMENT abos-20250331_htm.xml XML 819328
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

EIN.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40551 | Film No.: 25940798
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)